Zhu, Q., Cheng, J., Gao, Y., Zhang, Z., Pan, J., Su, X., . . . Xiao, P. (2025). NVP-2, in combination with Orlistat, represents a promising therapeutic strategy for acute myeloid leukemia. Cancer Biology & Therapy, 26(1), . https://doi.org/10.1080/15384047.2025.2450859
Chicago-referens (17:e uppl.)Zhu, Qing, et al. "NVP-2, in Combination with Orlistat, Represents a Promising Therapeutic Strategy for Acute Myeloid Leukemia." Cancer Biology & Therapy 26, no. 1 (2025). https://doi.org/10.1080/15384047.2025.2450859.
MLA-referens (9:e uppl.)Zhu, Qing, et al. "NVP-2, in Combination with Orlistat, Represents a Promising Therapeutic Strategy for Acute Myeloid Leukemia." Cancer Biology & Therapy, vol. 26, no. 1, 2025, https://doi.org/10.1080/15384047.2025.2450859.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.
